Publicaciones en colaboración con investigadores/as de Massachusetts Institute of Technology (10)

2023

  1. Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Mutant IDH Inhibits IFNg–TET2 Signaling to Promote Immunoevasion and Tumor Maintenance in Cholangiocarcinoma

    Cancer Discovery, Vol. 12, Núm. 3, pp. 812-835

  2. WAT3R: recovery of T-cell receptor variable regions from 3′ single-cell RNA-sequencing

    Bioinformatics, Vol. 38, Núm. 14, pp. 3645-3647

2021

  1. In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma

    Immunity, Vol. 54, Núm. 3, pp. 571-585.e6

2019

  1. Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade

    Nature, Vol. 565, Núm. 7737, pp. 43-48

2018

  1. Absence of MHC-II expression by lymph node stromal cells results in autoimmunity

    Life Science Alliance, Vol. 1, Núm. 6

2016

  1. An Evaluation Framework for Lossy Compression of Genome Sequencing Quality Values

    Data Compression Conference Proceedings

2010

  1. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response

    Cell, Vol. 142, Núm. 3, pp. 409-419

2009

  1. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals

    Nature, Vol. 458, Núm. 7235, pp. 223-227

  2. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, Núm. 28, pp. 11667-11672